Stock 000627 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Hubei Biocause Pharmaceutical Co., Ltd.

Equities

000627

CNE000000F48

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
2.29 CNY -2.55% Intraday chart for Hubei Biocause Pharmaceutical Co., Ltd. -6.91% -19.37%
Apr. 29 Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Life & Health Insurance

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. Stock Hubei Biocause Pharmaceutical Co., Ltd.
 1.56B - - - - -
AXA Stock AXA
 80.24B -
METLIFE, INC. Stock MetLife, Inc.
 51.58B
AFLAC INCORPORATED Stock Aflac Incorporated
 49.83B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
 47.73B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
 42.86B -
  1. Stock Market
  2. Equities
  3. 000627 Stock
  4. Charts Hubei Biocause Pharmaceutical Co., Ltd.
  5. Sector Chart